Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jan 31, 2025 · Filed Feb 4, 2025
The CEO of Cognition Therapeutics paid $30K out of pocket for Cognition Therapeutics shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$30,001
Shares × reported transaction price
$25K–$100K
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
79 days after results of Nov 13, 2024, 48 days before results of Mar 20, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −6.9% | −0.1% | −6.8% |
| 30 days | −34.3% | −4.7% | −29.6% |
| 90 days | −36.0% | −7.5% | −28.5% |
| 180 days | +9.4% | +4.5% | +4.9% |
| 365 days | +53.2% | +12.2% | +41.0% |
Past results only. Not a forecast.